Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline

Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline

FOSTER CITY, Calif. & MUNICH–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) in the present day introduced it has entered right into a definitive settlement to purchase Tubulis GmbH, a non-public Germany-based, clinical-stage biotechnology firm creating next-generation antibody-drug conjugates (ADCs), constructing on Gilead’s oncology pipeline, centered on addressing areas of excessive unmet want. The acquisition considerably expands…

Read Full News
2026-03-26 and the puzzle-to-publish pipeline: why Spelling Bee hint pages keep multiplying

2026-03-26 and the puzzle-to-publish pipeline: why Spelling Bee hint pages keep multiplying

2026-03-26 lands in the center of a transparent sample: a gradual stream of Spelling Bee hint-and-answer posts tied to particular puzzle dates, constructed round the similar core mechanic and the similar reader promise—assist if you’re caught, plus full solutions if you’re prepared to complete. What Happens When 2026-03-26 meets a day by day puzzle cadence?…

Read Full News